Biodexa Pharmaceuticals plc - American Depositary Shares (BDRX)
4.7800
+0.00 (0.00%)
NASDAQ · Last Trade: Dec 16th, 6:31 AM EST
Detailed Quote
Previous Close
4.780
Open
-
Bid
7.600
Ask
7.720
Day's Range
N/A - N/A
52 Week Range
3.580 - 92.00
Volume
2,794,298
Market Cap
31.96B
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
1,972,398
Chart
About Biodexa Pharmaceuticals plc - American Depositary Shares (BDRX)
Biodexa Pharmaceuticals is a biopharmaceutical company focused on advancing innovative therapies for the treatment of cancer and other serious diseases. The company specializes in developing proprietary drug delivery systems designed to enhance the therapeutic efficacy of existing drugs while minimizing side effects. By leveraging its expertise in nanomedicine and targeted delivery technologies, Biodexa strives to create safer, more effective treatment options to improve patient outcomes in oncology and beyond. Read More
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Myseum, Inc. (Nasdaq: MYSE) a leader in digital privacy and next-generation social media technology, today announced the successful completion of the sale of its approximately 35% minority ownership interest in RPM Interactive, Inc. (“RPM”), following Avalon GloboCare Corp.’s (Nasdaq: ALBT ) agreement to acquire 100% of RPM .
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
ENDRA Life Sciences (NASDAQ: NDRA) is redefining how emerging health-tech companies accelerate breakthrough innovation while maintaining disciplined capital efficiency. The developer of TAEUS® (Thermo-Acoustic Enhanced UltraSound) has implemented a modern treasury strategy managed by Arca Investment Management, converting idle cash into a structured, yield-generating engine that supports long-term growth without shareholder dilution.
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
